Fundraising Fox
/Companies
Sign in

Imio

Chicago, US · Founded 2023 · 11 employees on LinkedIn · 4 known investors

Find your way into Imio

Sign up to see every warm intro you have to Imio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Imio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Imio makes Re-Gen, a freeze-dried microbial powder applied to crop residue for row crops such as corn, helping farmers unlock NPK nutrient value and increase yields. The product is aimed at agricultural growers seeking fertilizer savings and higher output per acre.

AgTechBiotechClimate Tech

Founders & leadership

Imio was founded in 2023 by Charles Frederick Smith.

CF
Charles Frederick SmithFounder

Board

JB
Jeremiah BrewerBoard directorGeneral Partner at Starshot
GB
Guillaume BaxterBoard director

Investors · 4

Starshotlisted by StarshotLos Angeles
Workshop Venture Partnerslisted by Workshop Venture PartnersSan Francisco · $3M

How we know: Workshop Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us

Serra VenturesreportedChampaign · $5M

How we know: the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 1 round · 2026

▶$6MraisedJul 2026 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles Frederick SmithExecutive Officer, Director, Promoter
  • Jeremiah BrewerDirector
  • Guillaume BaxterDirector
Offering amount
$12M
Amount sold
$6M
First sale
Jun 2026
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

MiLaboratoriesUS-based AI-driven data intelligence platform for drug discovery and computational biology.
Mimio HealthMimio makes a daily supplement built from fasting metabolites that aims to recreate the cellular health and longevity benefits of prolonged fasting without requiring users to fast. The consumer product is positioned around autophagy support, healthy aging, appetite control, and metabolic health.
miDiagnosticsmiDiagnostics develops a portfolio of molecular diagnostic tests designed for rapid and accurate results to support healthcare professionals in clinical diagnosis and patient care.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Mahmi BioA company using artificial intelligence to identify natural proteins of interest, operating at the intersection of foodtech, immunology, and biotech.

Companies working in the same space as Imio.

Frequently asked questions

What does Imio do?
Imio makes Re-Gen, a freeze-dried microbial powder applied to crop residue for row crops such as corn, helping farmers unlock NPK nutrient value and increase yields. The product is aimed at agricultural growers seeking fertilizer savings and higher output per acre.
Who founded Imio?
Imio was founded by Charles Frederick Smith in 2023.
Who are Imio's investors?
Imio's investors include Nextwave [X] Partners, Starshot, Workshop Venture Partners, Serra Ventures.
How much funding has Imio raised?
Imio has disclosed $6M raised across 1 round.
Where is Imio headquartered?
Imio is headquartered in Chicago, US.